Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Paul W Jones, Henrik Watz, Emiel FM Wouters & Mario Cazzola. (2016) COPD: the patient perspective. International Journal of Chronic Obstructive Pulmonary Disease 11:sup1, pages 13-20.
Read now
Read now
B. Butorac-Petanjek, M.J. Parnham & S. Popović-Grle. (2010) Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Journal of Chemotherapy 22:5, pages 291-297.
Read now
Read now
Articles from other publishers (12)
Zhilin Zeng, Miao Li, Meijia Wang, Xiaomei Wu, Qinghai Li, Qin Ning, Jianping Zhao, Yongjian Xu & Jungang Xie. (2017) Increased expression of Siglec-9 in chronic obstructive pulmonary disease. Scientific Reports 7:1.
Crossref
Crossref
Dongdong Wang, Qingdan Du, Houcong Li & Shu Wang. (2016)
The Isosteroid Alkaloid Imperialine from Bulbs of
Fritillaria cirrhosa
Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat Model
. Mediators of Inflammation 2016, pages 1-17.
Crossref
Crossref
Malin L Nording, Jun Yang, Laura Hoang, Vanessa Zamora, Dale Uyeminami, Imelda Espiritu, Kent E Pinkerton, Bruce D Hammock & Ayala Luria. (2015) Bioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposure. Journal of Metabolomics 1:1, pages 1.
Crossref
Crossref
Lei Wang, Jun Yang, Lei Guo, Dale Uyeminami, Hua Dong, Bruce D. Hammock & Kent E. Pinkerton. (2012) Use of a Soluble Epoxide Hydrolase Inhibitor in Smoke-Induced Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology 46:5, pages 614-622.
Crossref
Crossref
Fabio L.M. Ricciardolo. (2007) The treatment of asthma in children: Inhaled corticosteroids. Pulmonary Pharmacology & Therapeutics 20:5, pages 473-482.
Crossref
Crossref
M.C. Rizzo, D. Solé & C.K. Naspitz. (2007) Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy. Allergologia et Immunopathologia 35:5, pages 197-208.
Crossref
Crossref
Clive P Page, Michael J Curtis, Michael J A Walker & Brian B Hoffman. 2006. Integrated Pharmacology. Integrated Pharmacology
259
275
.
Mark A. Birrell, Sissie Wong, David J. Hele, Kerryn McCluskie, Elizabeth Hardaker & Maria G. Belvisi. (2005) Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-κB Pathway Activation. American Journal of Respiratory and Critical Care Medicine 172:1, pages 74-84.
Crossref
Crossref
Michael J. Parnham, Ognjen Čulić, Vesna Eraković, Vesna Munić, Sanja Popović-Grle, Karmela Barišić, Martina Bosnar, Karmen Brajša, Ivana Čepelak, Snježana Čužić, Ines Glojnarić, Zoran Manojlović, Renata Novak-Mirčetić, Katarina Oresković, Verica Pavičić-Beljak, Senka Radošević & Mirna Sučić. (2005) Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. European Journal of Pharmacology 517:1-2, pages 132-143.
Crossref
Crossref
John G. Cumming, Caroline L. McKenzie, Stuart G. Bowden, Douglas Campbell, David J. Masters, Jason Breed & Philip J. Jewsbury. (2004) Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters 14:21, pages 5389-5394.
Crossref
Crossref
Hiroshi Ochiai, Yoshihiko Odagaki, Tazumi Ohtani, Akiharu Ishida, Kensuke Kusumi, Katuya Kishikawa, Susumu Yamamoto, Hiroshi Takeda, Takaaki Obata, Kaoru Kobayashi, Hisao Nakai & Masaaki Toda. (2004) Design, synthesis, and biological evaluation of new phosphodiesterase type 4 inhibitors. Bioorganic & Medicinal Chemistry 12:19, pages 5063-5078.
Crossref
Crossref
Maria G Belvisi & David J Hele. (2003) Soft steroids: a new approach to the treatment of inflammatory airways diseases. Pulmonary Pharmacology & Therapeutics 16:6, pages 321-325.
Crossref
Crossref